Pharmafile Logo

News and Press Releases

FASENRA​ approved in ​US​ for ​hypereosinophilic syndrome​

14 May 2026 -- Cambridge, UK -- AstraZeneca’s FASENRA (benralizumab) has been approved by the US FDA for the treatment of adult and pediatric patients aged 12 years and older with...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 14, 2026

CPHI and PMEC India 2026 expands to two venues, sets a new benchmark for focused global pharma engagement

India’s largest pharmaceutical platform by Informa Markets in India is set to return for its 19th edition with a milestone expansion. Debuting a dual‑venue format in Delhi NCR, the event...

Category: Other, Pharmaceutical
Posted: May 12, 2026

CPhI & P-MEC India
India Expo cCnter, Greater Noida, Delhi NCR, India

CPHI Americas 2026 unveils keynote speakers tackling pharma’s toughest challenges

11 May 2026 -- Pennsylvania, US -- Informa Markets has announced its keynote speaker line-up for CPHI Americas 2026 (June 2–4), bringing together more than 80 industry thought leaders, including...

Category: Biotechnology, Other, Pharmaceutical
Posted: May 11, 2026

Informa
media@informa.com
5 Howick Place London SW1P 1WG UK

U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder

29 April 2026 -- California, US -- Laguna Diagnostics, LLC today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s mRNA Gene...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 29, 2026

Laguna Diagnostics
info@lagunadiagnostics.com

U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Submission based on statistically significant event-free and overall survival data from the Phase 3 EV-304 trial Building on the existing indication in cisplatin-ineligible muscle-invasive bladder cancer (MIBC), if approved, this...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: April 20, 2026

Astellas
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan

Building the Future of Biotechnology — UK Biotech Day 2026

15 April 2026 -- London, UK -- UK Biotech Day 2026, taking place on 27–28 May 2026, will be held at the Radisson Hotel & Conference Centre London Heathrow. The...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 15, 2026

UK Biotech Day
register@ukbiotechday.org
Building A, Bath Road, Heathrow Boulevard, Sipson UB7 0DU, London, UK

ELRIG Announces Inaugural US Drug Discovery Conference

Free-to-attend event takes place at Pfizer in Cambridge, MA from 16–17 June Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets....

Category: Drug Discovery, Other, Pharmaceutical
Posted: April 14, 2026

European Laboratory Research and Innovation Group (ELRIG)
info@elrig.org
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

CWOW 2026: Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

26 March 2026 -- Cambridge, UK -- Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long,interactive festival with Oxford and London for...

Category: Drug Discovery, Other, Pharmaceutical
Posted: March 26, 2026

o2h
info@o2h.com
Mill SciTech Park, Mill Lane Hauxton, Cambridge CB22 5HX

SLAS Announces the Cohort for Innovation AveNEW at SLAS Europe 2026

Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, 19-21 May 2026 23 March 2026 -- Vienna, Austria -- SLAS, the...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 23, 2026

Society for Laboratory Automation and Screening
slas@slas.org
1301 West 22nd Street, Suite 708 Oak Brook, IL 60523 USA

BIO-Europe Spring 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon

16 March 2026 -- Munich, Germany -- The global biopharmaceutical community is preparing to gather in Lisbon, Portugal, for the 20th edition of BIO-Europe Spring, the premier springtime partnering conference...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 16, 2026

Informa
media@informa.com
5 Howick Place London SW1P 1WG UK

MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs

MAPS delegation includes senior researchers, policy experts, and Veterans from the US, Europe, Australia, and the Middle East The CND is a central drug policy-making body in the UN, playing...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 9, 2026

The Multidisciplinary Association for Psychedelic Studies (MAPS)
media@maps.org
3141 Stevens Creek Blvd #40563, San Jose, CA 95117

OBN Invites Life Science Leaders to Celebrate 20 Years of BioTrinity

Featuring keynotes from: Steve Bates, Executive Chair at the Office for Life Sciences, Lawrence Tallon, CEO at the MHRA & Maria Koufali, Life Sciences Industry Director at the NIHR, click...

Category: Other, Pharmaceutical
Posted: March 3, 2026

OBN
info@obn.org.uk
Unit 6 Library Avenue, Harwell, Didcot, OX11 0SG, UK

BIO-Europe Spring 2026 Charts the Future of Life Sciences from Lisbon’s Shores

25 February 2026 -- Munich, Germany -- The 20th annual BIO-Europe Spring is heading to Lisbon, Portugal, from March 23–25, 2026, with a digital experience to follow on March 31–April...

Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: February 25, 2026

Informa
media@informa.com
5 Howick Place London SW1P 1WG UK

Recipharm expands manufacturing to meet demanding FDA requirements

Established a new, dedicated non-bacterial beta-lactam manufacturing facility in response to FDA guidance Secured a strategic partnership with an innovative biopharma company seeking rapid regulatory compliance Developed a scalable platform...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 26, 2026

Recipharm

Levicept Announces FDA Acceptance of IND Application for LEVI-04, a Potentially Disease-Modifying Treatment for Osteoarthritis

20 January 2026 -- Sandwich, UK -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announces the US Food and...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 20, 2026

Levicept
info@levicept.com
Innovation House Discovery Park Ramsgate Road Sandwich Kent CT13 9ND